How to Enroll

PIANO is a national prospective registry study started in 2007 to determine whether the rates of birth defects, miscarriages, premature births and other outcomes in women with inflammatory bowel disease (IBD) taking azathioprine/6MP, biologic therapy or small molecules (infliximab, adalimumab, certolizumab, ustekinumab, vedolizumab, tofacitinb, etc.) are different from those among IBD-affected women not taking these medications.

How to Enroll

It is completely up to you if you would like to enroll in our study.  Please take the time to read over our consent form with family members and/or your doctor to see if this study is the best fit for you.
PIANO Registry (pdf)
If you are interested in enrolling in our study or have any questions about the study please contact our clinical research coordinator at [email protected] or 415-885-3734.